Vax-CAR-MILs

N/A

Report date: 2025/06/11 11:25:18

Base Information

Drug NameVax-CAR-MILs
Drug Alias NameCAR-MIL-cell therapy (VaxCell-Bio)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionImmunostimulantsLymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVaxcell Bio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVaxcell Bio Co Ltd
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A